Literature DB >> 2724306

Novel cytotoxic compounds from the ascidian Lissoclinum bistratum.

B M Degnan1, C J Hawkins, M F Lavin, E J McCaffrey, D L Parry, D J Watters.   

Abstract

The isolation and structures of two new cyclic hexapeptides and two new macrocyclic ethers from the aplousobranch ascidian Lissoclinum bistratum are described. Their structures were determined by two-dimensional NMR techniques. The hexapeptides, named bistratamide A and bistratamide B, differ only by the presence or absence of one double bond. They were tested for cytotoxicity toward human fibroblast and tumor cell lines and displayed similar toxicities to the octapeptides called patellamides from Lissoclinum patella. The peptides are found within the obligate algal symbiont Prochloron but clearly differ from peptides isolated from the same Prochloron of L. patella. The macrocyclic ethers isolated from L. bistratum are exceedingly potent in cytotoxicity. They have been named bistratenes A and B, and structures for these compounds are proposed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2724306     DOI: 10.1021/jm00126a035

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  INTEGRATED APPROACHES TO THE CONFIGURATIONAL ASSIGNMENT OF MARINE NATURAL PRODUCTS.

Authors:  Tadeusz F Molinski; Brandon I Morinaka
Journal:  Tetrahedron       Date:  2012-11-18       Impact factor: 2.457

2.  The secret to a successful relationship: lasting chemistry between ascidians and their symbiotic bacteria.

Authors:  Eric W Schmidt
Journal:  Invertebr Biol       Date:  2015-03-01       Impact factor: 1.250

Review 3.  Metagenomic approaches to natural products from free-living and symbiotic organisms.

Authors:  Sean F Brady; Luke Simmons; Jeffrey H Kim; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-09-16       Impact factor: 13.423

Review 4.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

5.  Species specificity of symbiosis and secondary metabolism in ascidians.

Authors:  Ma Diarey B Tianero; Jason C Kwan; Thomas P Wyche; Angela P Presson; Michael Koch; Louis R Barrows; Tim S Bugni; Eric W Schmidt
Journal:  ISME J       Date:  2014-08-29       Impact factor: 10.302

Review 6.  Life in cellulose houses: symbiotic bacterial biosynthesis of ascidian drugs and drug leads.

Authors:  Eric W Schmidt; Mohamed S Donia
Journal:  Curr Opin Biotechnol       Date:  2010-11-01       Impact factor: 9.740

7.  Ab initio calculations on peptide-derived oxazoles and thiazoles: improved molecular mechanics parameters for the AMBER force field.

Authors:  C D Boden; G Pattenden
Journal:  J Comput Aided Mol Des       Date:  1999-03       Impact factor: 3.686

8.  Accumulation of HL-60 leukemia cells in G2/M and inhibition of cytokinesis caused by two marine compounds, bistratene A and cycloxazoline.

Authors:  D J Watters; H J Beamish; K A Marshall; R A Gardiner; G J Seymour; M F Lavin
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 9.  Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria.

Authors:  Kaarina Sivonen; Niina Leikoski; David P Fewer; Jouni Jokela
Journal:  Appl Microbiol Biotechnol       Date:  2010-02-27       Impact factor: 4.813

10.  Effects of bistramide A on a non-small-cell bronchial carcinoma line.

Authors:  C Roussakis; N Robillard; D Riou; J F Biard; G Pradal; P Piloquet; C Debitus; J F Verbist
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.